Are Alzheimer's disease and other neurodegenerative disorders caused by impaired signalling of insulin and other hormones?
Neuropharmacology
.
2018 Jul 1;136(Pt B):159.
doi: 10.1016/j.neuropharm.2018.05.021.
Epub 2018 May 18.
Authors
Christian Hölscher
1
,
Fernanda G De Felice
2
,
Nigel H Greig
3
,
Sergio T Ferreira
4
Affiliations
1
Biomedical and Life Sciences, Lancaster University, Lancaster, UK. Electronic address: c.holscher@lancaster.ac.uk.
2
Centre for Neuroscience Studies, Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.
3
Drug Design & Development Section, Translational Gerontology Branch, National Institute on Aging, National Institutes of Health, Baltimore, USA.
4
Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
PMID:
29782874
PMCID:
PMC6192534
DOI:
10.1016/j.neuropharm.2018.05.021
No abstract available
Publication types
Editorial
Introductory Journal Article
MeSH terms
Alzheimer Disease / etiology*
Alzheimer Disease / metabolism*
Humans
Insulin / metabolism*
Parkinson Disease / etiology
Parkinson Disease / metabolism
Substances
Insulin
Grants and funding
Z99 AG999999/Intramural NIH HHS/United States
ZIA AG000333-10/Intramural NIH HHS/United States